文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

临床变量及肺部超声检查用于类风湿关节炎患者间质性肺疾病的筛查

Clinical variables and lung ultrasonography for the screening of interstitial lung disease in patients with rheumatoid arthritis.

作者信息

Edith Schneeberger Emilce, Miguel Perandones, Gabriel Rosemffet Marcos, María Otaola, Tomás Cazenave, Tatiana Barbich, Virginia Carrizo Abarza, Jonathan Balcazar, Gustavo Citera

机构信息

Rheumatology Section, Instituto de Rehabilitación Psicofísica (IREP), Buenos Aires, Argentina.

Pulmonology Section, Instituto de Rehabilitación Psicofísica (IREP), Buenos Aires, Argentina.

出版信息

Clin Rheumatol. 2025 Jun 24. doi: 10.1007/s10067-025-07510-z.


DOI:10.1007/s10067-025-07510-z
PMID:40555925
Abstract

UNLABELLED: The best screening way to detect interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA) is still debated. OBJECTIVES: To evaluate the performance of scores to identify patients with ILD in patients with RA. METHODS: Cross-sectional study, adult outpatients with RA were included and those with any disease that can affect lung ultrasonography (LUS) evaluation were excluded. Sociodemographic, clinical, and therapeutic variables were recorded. All patients underwent chest x-rays, pulmonary function tests (PFT), LUS, and high-resolution chest tomography (HRCT). Univariate and multivariate analyses and ROC curves. RESULTS: 107 patients with RA, median age of 62 years (IQR 36-84), 82.2% female, and median disease duration 14 years (IQR 1-42). A total of 30 patients (29.5%) had ILD by HRCT. The classic cutoff value of ≥ 5 B lines in the LUS (ILD by HRCT as the gold standard) showed an AUC of 0.86 (95% CI 0.78-0.94), Se 87.1%, and Sp 74.3% for the detection of ILD. A clinical score made up of 5 variables to identify the presence of ILD, based on the strength of association in the multivariate analysis: male sex, crackles, age ≥ 60 years, RF + , anti-CCP + . Range 0-11, cutoff value ≥ 5.5, AUC 0.80 (95% CI 0.70-0.89), Se 75%, and Sp 71%. When we added the LUS variable to this score: lines B ≥ 5, the range was 0-15, a cutoff value ≥ 7.5, AUC 0.88 (95% CI 0.81-0.94), Se improved to 84.4%, and Sp 75%. However, this last score did not exceed the performance of isolated LUS. CONCLUSIONS: LUS is a good tool for detecting ILD in patients with RA. Key Points • Interstitial lung disease (ILD) is an extra-musculoskeletal manifestation with high morbidity and mortality in patients with rheumatoid arthritis (RA). Early detection could improve the prognosis of these patients. • High-resolution chest tomography (HRCT) is the gold standard for ILD diagnosis, but high radiation and limited access hinder its use. • Lung ultrasound (LUS) is an excellent tool for detecting ILD in RA patients and performs better than clinical scores. • LUS provides a method of screening for ILD in patients with RA in a simple, cheap, safe, and effective way.

摘要

未标注:类风湿关节炎(RA)患者中检测间质性肺疾病(ILD)的最佳筛查方法仍存在争议。 目的:评估用于识别RA患者中ILD患者的评分的性能。 方法:横断面研究,纳入成年RA门诊患者,排除任何可影响肺部超声(LUS)评估的疾病患者。记录社会人口统计学、临床和治疗变量。所有患者均接受胸部X线、肺功能测试(PFT)、LUS和高分辨率胸部断层扫描(HRCT)。进行单变量和多变量分析以及ROC曲线分析。 结果:107例RA患者,中位年龄62岁(四分位间距36 - 84岁),82.2%为女性,中位病程14年(四分位间距1 - 42年)。共有30例(29.5%)患者经HRCT诊断为ILD。以HRCT诊断ILD为金标准,LUS中经典的≥5条B线截断值检测ILD的曲线下面积(AUC)为0.86(95%置信区间0.78 - 0.94),敏感度(Se)为87.1%,特异度(Sp)为74.3%。基于多变量分析中的关联强度,由5个变量组成的临床评分用于识别ILD的存在:男性、湿啰音、年龄≥60岁、类风湿因子阳性(RF +)、抗环瓜氨酸肽抗体阳性(anti - CCP +)。范围为0 - 11,截断值≥5.5,AUC为0.80(95%置信区间0.70 - 0.89),Se为75%,Sp为71%。当我们将LUS变量(B线≥5)添加到该评分中时,范围为0 - 15,截断值≥7.5,AUC为0.88(95%置信区间0.81 - 0.94),Se提高到84.4%,Sp为75%。然而,最后这个评分的性能未超过单独LUS的性能。 结论:LUS是检测RA患者中ILD的良好工具。要点•间质性肺疾病(ILD)是类风湿关节炎(RA)患者的一种肌肉骨骼外表现,发病率和死亡率高。早期检测可改善这些患者的预后。•高分辨率胸部断层扫描(HRCT)是ILD诊断的金标准,但高辐射和可及性有限阻碍了其应用。•肺部超声(LUS)是检测RA患者中ILD的优秀工具,且性能优于临床评分。•LUS以简单、廉价、安全和有效的方式为RA患者提供了一种ILD筛查方法。

相似文献

[1]
Clinical variables and lung ultrasonography for the screening of interstitial lung disease in patients with rheumatoid arthritis.

Clin Rheumatol. 2025-6-24

[2]
The diagnostic utility of lung ultrasound in the assessment of interstitial lung disease associated with rheumatoid arthritis.

Arthritis Res Ther. 2025-7-30

[3]
Computed tomography-based quantitative scoring system for rheumatoid arthritis-associated interstitial lung disease: a retrospective diagnostic accuracy study for progressive fibrosis detection.

Clin Rheumatol. 2025-7

[4]
Cyclophosphamide for connective tissue disease-associated interstitial lung disease.

Cochrane Database Syst Rev. 2018-1-3

[5]
Evaluation of the coalescent lung ultrasound score in rheumatoid arthritis-associated interstitial lung disease.

Clin Rheumatol. 2025-7-24

[6]
The potential of semi-quantitative and quantitative methods in predicting progression in rheumatoid arthritis-associated interstitial lung disease.

Clin Rheumatol. 2025-6

[7]
Anti-Inflammatory Versus Antifibrotic Therapies for the Management of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Protocol for a Systematic Review and Meta-Analysis.

JMIR Res Protoc. 2025-7-21

[8]
Lung ultrasound as a screening tool for interstitial lung disease in patients with rheumatoid arthritis: state of the art.

Curr Opin Pulm Med. 2025-9-1

[9]
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.

Clin Orthop Relat Res. 2024-12-1

[10]
Imaging aspects of interstitial lung disease in patients with rheumatoid arthritis: Literature review.

Autoimmun Rev. 2017-11-28

本文引用的文献

[1]
Impact of DMARD treatment and systemic inflammation on all-cause mortality in patients with rheumatoid arthritis and interstitial lung disease: a cohort study from the German RABBIT register.

RMD Open. 2024-4-4

[2]
Development of a Risk Nomogram Model for Identifying Interstitial Lung Disease in Patients With Rheumatoid Arthritis.

Front Immunol. 2022

[3]
Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology.

Reumatol Clin (Engl Ed). 2023-2

[4]
A Risk Score to Detect Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease.

Arthritis Rheumatol. 2022-11

[5]
The role of lung ultrasound B-lines and serum KL-6 in the screening and follow-up of rheumatoid arthritis patients for an identification of interstitial lung disease: review of the literature, proposal for a preliminary algorithm, and clinical application to cases.

Arthritis Res Ther. 2021-8-14

[6]
Interstitial lung abnormalities in patients with early rheumatoid arthritis: A pilot study evaluating prevalence and progression.

Eur J Rheumatol. 2018-10-1

[7]
Development of a risk indicator score for the identification of interstitial lung disease in patients with rheumatoid arthritis.

Reumatol Clin (Engl Ed). 2021-4

[8]
Pulmonary Complications of Rheumatoid Arthritis.

Semin Respir Crit Care Med. 2019-5-28

[9]
Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study.

Arthritis Rheumatol. 2019-8-4

[10]
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.

N Engl J Med. 2018-10-20

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索